Scientific Advisory Board

Edison Liu, MD

Edison Liu heads the Genome Institute of Singapore and serves in similar capacities as Executive Directors of the Singapore Cancer Syndicate and Singapore Tissue Network. Dr. Liu has won numerous awards for his work, most recently earning honors as Associate Member of the European Molecular Biology Organization (EMBO), Public Service Medal for controlling SARS in Singapore and an election to the board of directors at the American Association for Cancer Research. He has also served as President of the Human Genome Organisation (HUGO) and Chairman of the Health Sciences Authority in Singapore, among numerous other committees and advisory boards. Dr. Liu has authored more than 200 publications detailing his work on the involvement of kinases in cancer biology and molecular clinical epidemiology and functional genomics of human cancers. Dr. Liu earned his M.D. from Stanford University and was a resident at Barnes Hospital at Washington University, St. Louis.

Terry Speed, PhD

Terry Speed is currently the head of the Bioinformatics Division of the Walter & Eliza Hall Institute of Medical Research in Melbourne, Australia. Previously, Terry was on the statistics faculty at the University of California at Berkeley, with a research focus on statistical aspects of genetics and molecular biology. His team conducted basic research, collaborating with other biomedical scientists at schools such as Stanford University, the University of Michigan, Cornell University Medical School and various University of California campuses. He has an extensive relationship with the Life Sciences Division of the Lawrence Berkeley National Laboratory and has been closely involved with the U.S. National Cancer Institute’s Integrative Cancer Biology Program. Terry is a member of the Australian Cancer Research Foundation Centre for Therapeutic Target Discovery, the first initiative of the Melbourne Comprehensive Cancer Centre. He has a B.Sc. (Hons.) degree from the University of Melbourne and a Ph.D. from Monash University. His research is focused on applying statistics to biomedical research, concentrating on cancer genomics.

Lewis T. “Rusty” Williams, MD, PhD

Rusty Williams leads the research and development efforts at FivePrime Therapeutics, Inc., as its founder and Executive Chairman. Previously, he has held positions such as Chief Scientific Officer, board of directors member and President of Chiron Technologies. He has served in similar capacities as cofounder and board of directors member of COR Therapeutics, Inc. Earlier in his career, Dr. Williams was a Howard Hughes Medical Investigator at the University of California, San Francisco, and a staff cardiologist at Massachusetts General Hospital. He is a National Academy of Sciences member and a fellow of the American Academy of Arts & Sciences. Dr. Williams earned his M.D. and Ph.D. degrees from Duke University and was trained in internal medicine and cardiology at Massachusetts General Hospital.